This independent HPLC-UV/VIS lab test confirms FOXO4-DRI 10mg from Kimera Chems at 99.80% purity. The analysis was conducted by Vanguard Laboratory on November 11, 2025.
FOXO4-DRI is a peptide researched for its role in disrupting the interaction between FOXO4 and p53, with potential applications in cellular senescence and longevity research. A purity level of 99.80% indicates minimal contamination and high-grade synthesis.
Sterility testing passed with no growth detected. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.